Pharmaceutical company payments to the authors of the Japanese dementia clinical practice guidelines in 2016
Abstract Introduction Financial relationships between pharmaceutical companies and dementia clinical practice guideline (CPG) authors are possibly biasing the recommendations in Japan. This study aimed to reveal characteristics and distribution of pharmaceutical payments made to Japanese dementia CP...
Saved in:
| Main Authors: | Yuki Shimada, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Tetsuya Tanimoto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Subjects: | |
| Online Access: | https://doi.org/10.1016/j.trci.2019.05.003 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative risk assessment of non-communicable diseases by evacuation scenario– a retrospective study in the 7 years following the Fukushima Daiichi nuclear power plant accident
by: Shuhei Nomura, et al.
Published: (2021-01-01) -
Beyond pharmaceuticals: Holistic strategies for cognitive health
by: Liang-Kung Chen, MD, PhD
Published: (2024-12-01) -
PUFA, fish intake and risk of disabling dementia in Japan: the Japan Public Health Centre Disabling Dementia Study
by: Sarah K Abe, et al.
Published: (2025-01-01) -
Accuracy of Death Certificates in Attributing Mortality to Alzheimer’s Disease and Other Dementias in Japanese Psychiatric Hospitals
by: Sato K, et al.
Published: (2025-07-01) -
Development of the dementia attitude scale focusing on well-being
by: Ichie Ono, et al.
Published: (2024-11-01)